Signal transducer and activator of transcription 5 (STAT5)

International Journal of Biochemistry and Cell Biology

Volumn 36, Issue 11, 2004, Pages 2120-2124

  Buitenhuis, Miranda ^a   Coffer, Paul J ^a   Koenderman, Leo ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cytokines; hematopoiesis; Signal transduction; STAT5

Indexed keywords

CYTOKINE; ENZYME INHIBITOR; GROWTH FACTOR; GTP 14564; PHOSPHOTRANSFERASE INHIBITOR; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; DRUG TARGETING; GENE TARGETING; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION INITIATION;

EID: 4143149692     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2003.11.008     Document Type: Short Survey

References (12)

1. + cells. Blood. 101(1):2003;134-142
2. Bunting K.D., Bradley H.L., Hawley T.S., Moriggl R., Sorrentino B.P., Ihle J.N. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver mice lacking expression of STAT5. Blood. 99(2):2002;479-487
3. Coffer P.J., Koenderman L., de Groot R.P. The role of STATs on myeloid differentiation and leukemia. Oncogene. 19(21):2000;2511-2522
4. Hirokawa S., Sato H., Kato I., Kudo A. EBF-regulating Pax5 transcription is enhanced by STAT5 in the early stage of B-cells. European Journal of Immunology. 33(7):2003;1824-1829
5. Levy D.E., Darnell J.E. STATs: transcriptional control and biological impact. Nature Review of Molecular and Cellular Biology. 3(9):2002;651-662
6. Levy D.E., Lilliland D.G. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice. Oncogene. 19(21):2000;2505-2510
7. Murata K., Kumagai H., Tamitsu K., Irie M., Nakajima H., Suzu S., Shibuya M., Kamihira S., Nosaka T., Asano S., Kitamura T. Selective cytotoxic mechanism of GTP-14564, a novel tyrosine kinase inhibitor in leukemia cells expressing a constitutively active FLT3 3 (FLT3). Journal of Biological Chemistry. 278:2003;32892-32898
8. Park S.H., Yamashita H., Rui H., Waxman D.J. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity. Molecular Endocrinology. 15:2001;2157-2171
9. Rane S.G., Reddy E.P. Jaks, STATs and Src kinases in hematopoiesis. Oncogene. 21(21):2002;3334-3358
10. Wang D., Moriggl R., Stravopodis D., Carpino N., Marine J.C., Teglund S., Feng J., Ihle J.N. A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5. The EMBO Journal. 19:2000;392-399
11. Wang R.A., Vadlamudi R.K., Bagheri-Yarmand R., Beuvink I., Hynes N.E., Kumar R. Essential functions of p21-activated kinase 1 in morphogenesis and differentiation of mammary glands. The Journal of Cellular Biology. 161:2003;583-592
12. Xi S., Zhang Q., Dyer K.F., Lerner E.C., Smithgall T.E., Goodings W.E., Kamens J., & Rubin Grandis J. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. Journal of Biological Chemistry. 278(34):2003;31574-31583